| C026486 | 1,2,5,6-dibenzanthracene | "1,2,5,6-dibenzanthracene results in decreased expression of CXCL5 mRNA" | 26377693 |
| C032668 | 1-nitropyrene | 1-nitropyrene results in increased expression of CXCL5 mRNA | 19428942 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CXCL5 mRNA" | 23146750 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CXCL5 mRNA" | 23146750 |
| C511621 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [IL1B protein results in increased expression of CXCL5 mRNA] | 28973351 |
| C511621 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide results in decreased expression of CXCL5 mRNA | 28973351 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CXCL5 mRNA" | 23146750 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CXCL5 mRNA" | 19692669 |
| C014464 | 3,4-dichloroaniline | "3,4-dichloroaniline results in increased expression of CXCL5 mRNA" | 24172598 |
| C091768 | 3'-methoxy-4'-nitroflavone | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CXCL5 mRNA] | 21441140 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL5 mRNA" | 27188386 |
| C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased expression of CXCL5 mRNA | 12419474 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL5 mRNA" | 27188386 |
| C111855 | 6-formylindolo(3,2-b)carbazole | "6-formylindolo(3,2-b)carbazole results in increased expression of CXCL5 mRNA" | 28973351 |
| C111855 | 6-formylindolo(3,2-b)carbazole | "IL1B protein promotes the reaction [6-formylindolo(3,2-b)carbazole results in increased expression of CXCL5 mRNA]" | 28973351 |
| C496492 | abrine | abrine results in decreased expression of CXCL5 mRNA | 22595364 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of CXCL5 mRNA | 26690555 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of CXCL5 mRNA | 17562736 |
| D000082 | Acetaminophen | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CXCL5 mRNA] | 18700144 |
| D000393 | Air Pollutants | Air Pollutants analog results in increased expression of CXCL5 mRNA | 21757418 |
| D000393 | Air Pollutants | Air Pollutants results in increased expression of CXCL5 mRNA | 18367723 |
| D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of CXCL5 mRNA | 24449571 |
| D001151 | Arsenic | Arsenic results in decreased expression of CXCL5 mRNA | 19962721 |
| D001151 | Arsenic | Fluorides inhibits the reaction [Arsenic results in decreased expression of CXCL5 mRNA] | 19962721 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CXCL5 mRNA | 22521957 |
| C015001 | arsenite | arsenite results in increased expression of CXCL5 mRNA | 18929588 |
| C015001 | arsenite | TRP53 protein affects the reaction [arsenite results in increased expression of CXCL5 mRNA] | 18929588 |
| D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of CXCL5 mRNA" | 18687144|2416032 |
| D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in decreased expression of CXCL5 mRNA" | 26839332 |
| D001241 | Aspirin | Aspirin results in increased expression of CXCL5 mRNA | 12800193 |
| C487081 | belinostat | belinostat results in increased expression of CXCL5 mRNA | 26272509 |
| C487081 | belinostat | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL5 mRNA" | 27188386 |
| C030935 | benz(a)anthracene | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCL5 mRNA | 27858113 |
| C006703 | benzo(b)fluoranthene | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCL5 mRNA | 27858113 |
| C006703 | benzo(b)fluoranthene | benzo(b)fluoranthene results in decreased expression of CXCL5 mRNA | 26377693 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of CXCL5 mRNA | 28973351 |
| D019324 | beta-Naphthoflavone | IL1B protein promotes the reaction [beta-Naphthoflavone results in increased expression of CXCL5 mRNA] | 28973351 |
| D001564 | Benzo(a)pyrene | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCL5 mRNA | 27858113 |
| D004958 | Estradiol | Estradiol inhibits the reaction [IL1B protein results in increased expression of CXCL5 mRNA] | 12072388 |
| D004958 | Estradiol | Estradiol results in increased expression of CXCL5 mRNA | 19484750 |
| C006780 | bisphenol A | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CXCL5 mRNA | 28628672 |
| C000611646 | bisphenol F | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CXCL5 mRNA | 28628672 |
| C006794 | brevianamide A | brevianamide A results in decreased expression of CXCL5 mRNA | 19818335 |
| C006794 | brevianamide A | brevianamide A results in increased expression of CXCL5 mRNA | 19818335 |
| C018475 | butyraldehyde | butyraldehyde results in increased expression of CXCL5 mRNA | 26079696 |
| D002104 | Cadmium | Cadmium results in increased expression of CXCL5 mRNA | 21120746 |
| D002118 | Calcium | [CTSS protein results in increased cleavage of and results in increased activity of CXCL5 protein] which results in increased uptake of Calcium | 25833952 |
| D002118 | Calcium | [CXCL5 protein modified form binds to and results in increased activity of CXCR2 protein] which results in increased uptake of Calcium | 25833952 |
| D002211 | Capsaicin | Capsaicin results in increased expression of CXCL5 protein | 22150557 |
| D002211 | Capsaicin | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL5 protein] | 22150557 |
| D002211 | Capsaicin | Naproxen inhibits the reaction [Capsaicin results in increased expression of CXCL5 protein] | 22150557 |
| D002211 | Capsaicin | Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CXCL5 protein] | 22150557 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of CXCL5 mRNA | 17484886 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in decreased expression of CXCL5 mRNA | 23650126 |
| D002737 | Chloroprene | Chloroprene results in increased expression of CXCL5 mRNA | 23125180 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CXCL5 mRNA | 20938992 |
| C031180 | chrysene | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCL5 mRNA | 27858113 |
| C031180 | chrysene | chrysene results in decreased expression of CXCL5 mRNA | 26377693 |
| C000488 | cladosporin | cladosporin results in decreased expression of CXCL5 mRNA | 19818335 |
| D003024 | Clozapine | Clozapine results in decreased expression of CXCL5 mRNA | 17346280 |
| D003035 | Cobalt | TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA] | 23503329 |
| D003035 | Cobalt | [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA | 23503329 |
| C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of CXCL5 mRNA | 19376846 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased expression of CXCL5 mRNA | 23052192 |
| D003436 | Croton Oil | Croton Oil results in increased expression of CXCL5 mRNA | 19647056 |
| C038459 | curdlan | curdlan results in increased expression of CXCL5 mRNA | 21356202 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of CXCL5 mRNA | 15331540 |
| C014347 | decitabine | decitabine results in decreased methylation of CXCL5 promoter | 20562917 |
| C014347 | decitabine | decitabine results in increased expression of CXCL5 mRNA | 20562917 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased expression of CXCL5 mRNA | 27757495 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CXCL5 mRNA | 28628672 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CXCL5 mRNA | 28628672 |
| D003907 | Dexamethasone | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA | 16054899 |
| D003907 | Dexamethasone | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA] | 16054899 |
| D003907 | Dexamethasone | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA] | 16054899 |
| D003907 | Dexamethasone | TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA] | 23503329 |
| D003907 | Dexamethasone | [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA | 23503329 |
| D016264 | Dextran Sulfate | Dextran Sulfate results in increased expression of CXCL5 mRNA | 19645018 |
| D002945 | Cisplatin | Cisplatin promotes the reaction [jinfukang results in decreased expression of CXCL5 mRNA] | 27392435 |
| D002945 | Cisplatin | jinfukang promotes the reaction [Cisplatin results in decreased expression of CXCL5 mRNA] | 27392435 |
| C058705 | diethyl malate | diethyl malate affects the expression of CXCL5 mRNA | 24814887 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in decreased expression of CXCL5 mRNA | 15171707 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased expression of CXCL5 mRNA | 19647056 |
| D004237 | Diuron | Diuron metabolite results in increased expression of CXCL5 mRNA | 24172598 |
| D004317 | Doxorubicin | CXCL5 protein affects the susceptibility to Doxorubicin | 16217747 |
| C118739 | entinostat | entinostat results in increased expression of CXCL5 mRNA | 26272509 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL5 mRNA" | 27188386 |
| D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with ESR1 protein] inhibits the reaction [IL1B protein results in increased expression of CXCL5 mRNA] | 12072388 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol inhibits the reaction [IL1B protein results in increased expression of CXCL5 mRNA] | 12072388 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of CXCL5 mRNA | 15212814|1583489 |
| D005459 | Fluorides | Fluorides inhibits the reaction [Arsenic results in decreased expression of CXCL5 mRNA] | 19962721 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CXCL5 mRNA | 20938992 |
| C069837 | fullerene C60 | fullerene C60 results in increased expression of CXCL5 mRNA | 20471445 |
| C039281 | furan | furan results in increased expression of CXCL5 mRNA | 27387713 |
| C007834 | genipin | genipin inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL5 mRNA] | 22687549 |
| D019833 | Genistein | Genistein inhibits the reaction [IL1B protein results in increased expression of CXCL5 mRNA] | 12072388 |
| D005944 | Glucosamine | Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL5 mRNA] | 17109745 |
| C412815 | GW 4064 | GW 4064 results in increased expression of CXCL5 mRNA | 26655953 |
| D006581 | Hexachlorobenzene | Hexachlorobenzene results in increased expression of CXCL5 mRNA | 15159207 |
| D017313 | Fenretinide | Fenretinide results in increased expression of CXCL5 mRNA | 16467112 |
| C041508 | indeno(1,2,3-cd)pyrene | "indeno(1,2,3-cd)pyrene results in decreased expression of CXCL5 mRNA" | 26377693 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CXCL5 mRNA | 28628672 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CXCL5 mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CXCL5 mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CXCL5 mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA | 16054899 |
| D015056 | 1-Methyl-3-isobutylxanthine | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA] | 16054899 |
| D015056 | 1-Methyl-3-isobutylxanthine | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA] | 16054899 |
| D015056 | 1-Methyl-3-isobutylxanthine | TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA] | 23503329 |
| D015056 | 1-Methyl-3-isobutylxanthine | [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA | 23503329 |
| C544151 | jinfukang | Cisplatin promotes the reaction [jinfukang results in decreased expression of CXCL5 mRNA] | 27392435 |
| C544151 | jinfukang | jinfukang promotes the reaction [Cisplatin results in decreased expression of CXCL5 mRNA] | 27392435 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of CXCL5 mRNA | 26752646 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 results in increased expression of CXCL5 mRNA" | 23306164 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CXCL5 mRNA | 19428942 |
| D008070 | Lipopolysaccharides | genipin inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL5 mRNA] | 22687549 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CXCL5 mRNA | 21356202|2268754 |
| C106335 | macrophage stimulatory lipopeptide 2 | HIF1A protein promotes the reaction [[macrophage stimulatory lipopeptide 2 co-treated with nickel sulfate] results in increased secretion of CXCL5 protein] | 18832182 |
| C106335 | macrophage stimulatory lipopeptide 2 | [nickel sulfate co-treated with macrophage stimulatory lipopeptide 2] results in increased expression of CXCL5 mRNA | 18832182 |
| C106335 | macrophage stimulatory lipopeptide 2 | [nickel sulfate co-treated with macrophage stimulatory lipopeptide 2] results in increased secretion of CXCL5 protein | 18832182 |
| C106335 | macrophage stimulatory lipopeptide 2 | PTGS2 protein promotes the reaction [[nickel sulfate co-treated with macrophage stimulatory lipopeptide 2] results in increased secretion of CXCL5 protein] | 18832182 |
| D058185 | Magnetite Nanoparticles | Magnetite Nanoparticles results in increased expression of CXCL5 mRNA | 25266609 |
| D058185 | Magnetite Nanoparticles | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL5 mRNA | 26378955 |
| D008345 | Manganese | Manganese results in increased expression of CXCL5 mRNA | 18284614 |
| D008628 | Mercury | Mercury results in increased expression of CXCL5 mRNA | 12730625 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CXCL5 mRNA | 20938992 |
| D008748 | Methylcholanthrene | [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CXCL5 mRNA | 23519560 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of CXCL5 mRNA | 28001369 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of CXCL5 mRNA | 24213012 |
| D015735 | Mifepristone | Mifepristone results in increased expression of CXCL5 mRNA | 17584828 |
| D016685 | Mitomycin | CXCL5 protein affects the susceptibility to Mitomycin | 16217747 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of CXCL5 mRNA | 18988085 |
| D009173 | Mycophenolic Acid | Mycophenolic Acid results in decreased expression of CXCL5 mRNA | 19818335 |
| D009173 | Mycophenolic Acid | Mycophenolic Acid results in increased expression of CXCL5 mRNA | 19818335 |
| D009183 | Mycotoxins | Mycotoxins affects the expression of CXCL5 mRNA | 21356202 |
| D009183 | Mycotoxins | Mycotoxins results in decreased expression of CXCL5 mRNA | 19818335 |
| D009183 | Mycotoxins | Mycotoxins results in increased expression of CXCL5 mRNA | 19818335 |
| C560625 | N-(2-(3H-indol-3-yl)ethyl)-9-isopropyl-2-(5-methyl-3-pyridyl)purin-6-amine | N-(2-(3H-indol-3-yl)ethyl)-9-isopropyl-2-(5-methyl-3-pyridyl)purin-6-amine inhibits the reaction [IL1B protein results in increased expression of CXCL5 mRNA] | 28973351 |
| C560625 | N-(2-(3H-indol-3-yl)ethyl)-9-isopropyl-2-(5-methyl-3-pyridyl)purin-6-amine | N-(2-(3H-indol-3-yl)ethyl)-9-isopropyl-2-(5-methyl-3-pyridyl)purin-6-amine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CXCL5 mRNA] | 28973351 |
| C560625 | N-(2-(3H-indol-3-yl)ethyl)-9-isopropyl-2-(5-methyl-3-pyridyl)purin-6-amine | N-(2-(3H-indol-3-yl)ethyl)-9-isopropyl-2-(5-methyl-3-pyridyl)purin-6-amine results in decreased expression of CXCL5 mRNA | 28973351 |
| C058346 | N-(4-methoxyphenyl)retinamide | N-(4-methoxyphenyl)retinamide results in increased expression of CXCL5 mRNA | 16467112 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in increased expression of CXCL5 mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of CXCL5 mRNA" | 25554681|2683933 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of CXCL5 mRNA" | 19836432|2491129 |
| D009288 | Naproxen | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL5 protein] | 22150557 |
| D009288 | Naproxen | Naproxen inhibits the reaction [Capsaicin results in increased expression of CXCL5 protein] | 22150557 |
| C015380 | neoechinulin | neoechinulin results in decreased expression of CXCL5 mRNA | 19818335 |
| C490266 | neoechinulin A | neoechinulin A results in decreased expression of CXCL5 mRNA | 19818335 |
| C490266 | neoechinulin A | neoechinulin A results in increased expression of CXCL5 mRNA | 21356202 |
| D009532 | Nickel | TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA] | 23503329 |
| D009532 | Nickel | [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA | 23503329 |
| C022838 | nickel chloride | nickel chloride results in increased expression of CXCL5 mRNA | 17312168 |
| C029938 | nickel sulfate | HIF1A protein promotes the reaction [[macrophage stimulatory lipopeptide 2 co-treated with nickel sulfate] results in increased secretion of CXCL5 protein] | 18832182 |
| C029938 | nickel sulfate | [nickel sulfate co-treated with macrophage stimulatory lipopeptide 2] results in increased expression of CXCL5 mRNA | 18832182 |
| C029938 | nickel sulfate | [nickel sulfate co-treated with macrophage stimulatory lipopeptide 2] results in increased secretion of CXCL5 protein | 18832182 |
| C029938 | nickel sulfate | PTGS2 protein promotes the reaction [[nickel sulfate co-treated with macrophage stimulatory lipopeptide 2] results in increased secretion of CXCL5 protein] | 18832182 |
| D015112 | 4-Nitroquinoline-1-oxide | 4-Nitroquinoline-1-oxide results in increased expression of CXCL5 mRNA | 27148699 |
| C572573 | N-nitroso-tris-chloroethylurea | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of CXCL5 mRNA | 27935865 |
| C572573 | N-nitroso-tris-chloroethylurea | [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CXCL5 mRNA | 27935865 |
| D009828 | Oleanolic Acid | Oleanolic Acid results in increased expression of CXCL5 mRNA | 18706400 |
| C510784 | ormosil | [ormosil binds to Polyethylene Glycols] which results in increased expression of CXCL5 mRNA | 24888373 |
| D010081 | Oxazolone | Oxazolone results in increased expression of CXCL5 mRNA | 19647056 |
| D010126 | Ozone | IL4 protein affects the reaction [Ozone results in increased expression of CXCL5 mRNA] | 18417511 |
| D010126 | Ozone | Ozone results in increased expression of CXCL5 mRNA | 14754758|1841751 |
| D010126 | Ozone | Ozone results in increased expression of CXCL5 protein | 23434795 |
| D017239 | Paclitaxel | CXCL5 protein affects the susceptibility to Paclitaxel | 16217747 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL5 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of CXCL5 mRNA | 26272509 |
| D010261 | Paraoxon | Paraoxon results in increased expression of CXCL5 mRNA | 24413757 |
| D052638 | Particulate Matter | Particulate Matter results in decreased expression of CXCL5 mRNA | 22178795 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of CXCL5 mRNA | 24769257 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of CXCL5 protein | 24060272 |
| D010457 | Peptidoglycan | Peptidoglycan results in increased expression of CXCL5 mRNA | 15860229 |
| D010575 | Pesticides | Pesticides results in decreased expression of CXCL5 mRNA | 27406225 |
| D010656 | Phenylephrine | Phenylephrine results in decreased expression of CXCL5 mRNA | 18158353 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL5 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of CXCL5 mRNA | 26272509 |
| C060836 | pioglitazone | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of CXCL5 mRNA | 27935865 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of CXCL5 mRNA | 18518955 |
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CXCL5 mRNA | 19710929 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of CXCL5 mRNA | 21297082 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of CXCL5 protein | 21297082 |
| D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls affects the expression of CXCL5 mRNA | 21334430 |
| D011092 | Polyethylene Glycols | [ormosil binds to Polyethylene Glycols] which results in increased expression of CXCL5 mRNA | 24888373 |
| C060540 | polyhexamethyleneguanidine | polyhexamethyleneguanidine results in increased expression of CXCL5 mRNA | 27989595 |
| C009041 | primycin | primycin results in increased expression of CXCL5 mRNA | 28916286 |
| D011374 | Progesterone | Progesterone results in increased expression of CXCL5 mRNA | 18070364 |
| D011374 | Progesterone | Progesterone affects the expression of CXCL5 mRNA | 17251523 |
| C005556 | propionaldehyde | propionaldehyde results in increased expression of CXCL5 mRNA | 26079696 |
| D011791 | Quartz | Quartz results in increased expression of CXCL5 mRNA | 19836432 |
| D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride inhibits the reaction [IL1B protein results in increased expression of CXCL5 mRNA] | 12072388 |
| C059514 | resveratrol | resveratrol results in decreased expression of CXCL5 mRNA | 25280562 |
| D019438 | Ritonavir | Ritonavir results in decreased expression of CXCL5 | 26626330 |
| C089730 | rosiglitazone | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA | 16054899 |
| C089730 | rosiglitazone | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA] | 16054899 |
| C089730 | rosiglitazone | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA] | 16054899 |
| D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in increased expression of CXCL5 mRNA" | 24160326 |
| C551534 | SGA 360 | SGA 360 inhibits the reaction [IL1B protein results in increased expression of CXCL5 mRNA] | 28973351 |
| C551534 | SGA 360 | SGA 360 inhibits the reaction [IL1B protein results in increased expression of CXCL5 protein] | 28973351 |
| C551534 | SGA 360 | SGA 360 results in decreased expression of CXCL5 mRNA | 28973351 |
| C551534 | SGA 360 | SGA 360 results in decreased expression of CXCL5 protein | 28973351 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in increased expression of CXCL5 mRNA | 25895662 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of CXCL5 mRNA | 19428942|2421153 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of CXCL5 mRNA | 23221170 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of CXCL5 mRNA | 22431001 |
| D019821 | Simvastatin | Simvastatin results in decreased expression of CXCL5 mRNA | 16414398 |
| D012906 | Smoke | Smoke results in increased expression of CXCL5 mRNA | 21095227 |
| D012906 | Smoke | Smoke results in increased expression of CXCL5 mRNA | 23306164 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of CXCL5 mRNA | 21911445 |
| D012969 | Sodium Fluoride | Sodium Fluoride results in decreased expression of CXCL5 mRNA | 21340527 |
| D053260 | Soot | Soot results in increased expression of CXCL5 mRNA | 19165387|2246145 |
| D013241 | Sterigmatocystin | Sterigmatocystin results in decreased expression of CXCL5 mRNA | 19818335|2135620 |
| D004113 | Succimer | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL5 mRNA | 26378955 |
| D018170 | Sumatriptan | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL5 protein] | 22150557 |
| D018170 | Sumatriptan | Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CXCL5 protein] | 22150557 |
| D013656 | Taurocholic Acid | EGR1 promotes the reaction [Taurocholic Acid results in increased expression of CXCL5 mRNA] | 21224055 |
| D013656 | Taurocholic Acid | Taurocholic Acid results in increased expression of CXCL5 mRNA | 21224055 |
| D013749 | Tetrachlorodibenzodioxin | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CXCL5 mRNA] | 21441140 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CXCL5 mRNA | 21441140 |
| D013749 | Tetrachlorodibenzodioxin | AHRR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CXCL5 mRNA] | 26862745 |
| D013749 | Tetrachlorodibenzodioxin | IL1B protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CXCL5 mRNA] | 28973351 |
| D013749 | Tetrachlorodibenzodioxin | N-(2-(3H-indol-3-yl)ethyl)-9-isopropyl-2-(5-methyl-3-pyridyl)purin-6-amine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CXCL5 mRNA] | 28973351 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA] | 16054899 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of CXCL5 mRNA | 16054899 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA] | 16054899 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of CXCL5 mRNA] | 15667827 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [[AHR protein binds to ARNT protein] which binds to CXCL5 promoter] | 28973351 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CXCL5 mRNA | 16054899|2686274 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CXCL5 mRNA | 19692669 |
| D013755 | Tetradecanoylphorbol Acetate | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CXCL5 mRNA | 16979875 |
| D013755 | Tetradecanoylphorbol Acetate | [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CXCL5 mRNA | 23519560 |
| C009495 | titanium dioxide | titanium dioxide results in increased expression of CXCL5 mRNA | 21259345|2355797 |
| C402696 | TMC 120A | TMC 120A results in decreased expression of CXCL5 mRNA | 19818335 |
| C402696 | TMC 120A | TMC 120A results in increased expression of CXCL5 mRNA | 21356202 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution affects the expression of CXCL5 mRNA | 27404394 |
| D014028 | Tobacco Smoke Pollution | [APOE gene mutant form affects the susceptibility to Tobacco Smoke Pollution] which results in increased expression of CXCL5 mRNA | 24096154 |
| D014028 | Tobacco Smoke Pollution | [APOE gene mutant form affects the susceptibility to Tobacco Smoke Pollution] which results in increased expression of CXCL5 protein | 24096154 |
| D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of CXCL5 mRNA] | 20133372 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution affects the expression of CXCL5 mRNA | 20133372 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution deficiency inhibits the reaction [[APOE gene mutant form affects the susceptibility to Tobacco Smoke Pollution] which results in increased expression of CXCL5 protein] | 24096154 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of and results in increased secretion of CXCL5 protein | 24752502 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of CXCL5 mRNA | 24752502 |
| D014051 | Toluene 2,4-Diisocyanate | "Toluene 2,4-Diisocyanate results in increased expression of CXCL5 mRNA" | 19647056 |
| D014118 | Toxins, Biological | "Toxins, Biological affects the expression of CXCL5 mRNA" | 19682533 |
| C012589 | trichostatin A | trichostatin A results in decreased acetylation of CXCL5 protein | 20562917 |
| C012589 | trichostatin A | trichostatin A results in increased expression of CXCL5 mRNA | 24935251|2627250 |
| D014302 | Trinitrobenzenesulfonic Acid | Trinitrobenzenesulfonic Acid results in increased expression of CXCL5 mRNA | 17982090 |
| D017973 | Tungsten Compounds | Tungsten Compounds results in increased expression of CXCL5 mRNA | 28666766 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL5 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of CXCL5 mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of CXCL5 mRNA | 23179753 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of CXCL5 mRNA | 23179753|2438349 |
| D014638 | Vanadates | Vanadates results in decreased expression of CXCL5 mRNA | 22714537 |
| D001335 | Vehicle Emissions | Vehicle Emissions affects the expression of CXCL5 mRNA | 18192680 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of CXCL5 protein | 24060272 |
| D014747 | Vinblastine | CXCL5 protein affects the susceptibility to Vinblastine | 16217747 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL5 mRNA" | 27188386 |
| C111237 | vorinostat | vorinostat results in increased expression of CXCL5 mRNA | 26272509 |
| C581157 | XL147 | [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CXCL5 mRNA | 27935865 |
| D015032 | Zinc | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CXCL5 mRNA | 16979875 |
| D015032 | Zinc | TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA] | 23503329 |
| D015032 | Zinc | [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA | 23503329 |
| D015032 | Zinc | Zinc deficiency results in increased expression of CXCL5 mRNA | 22689922 |
| D015032 | Zinc | Zinc deficiency results in increased expression of CXCL5 protein | 22689922 |
| C016837 | zinc chloride | zinc chloride results in increased expression of CXCL5 mRNA | 19428942 |
| D019287 | Zinc Sulfate | Zinc Sulfate results in increased expression of CXCL5 mRNA | 16330358 |
| C088658 | zoledronic acid | zoledronic acid results in increased expression of CXCL5 mRNA | 24714768 |